세계의 방사면역측정법 시장(2024-2028년)

The radioimmunoassay market is forecasted to grow by USD 1.73 bn during 2023-2028, accelerating at a CAGR of 4.82% during the forecast period. The report on the radioimmunoassay market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of pharmaceutical and biotechnology industries, rise in prevalence of infectious diseases, and growing geriatric population.

Technavio's radioimmunoassay market is segmented as below:

By Application

• Clinical diagnostics
• Research

By Product

• Reagents
• kits
• Analyzers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the shift towards automation and integration into radioimmunoassay systems as one of the prime reasons driving the radioimmunoassay market growth during the next few years. Also, development of radioimmunoassay-based point-of-care devices and increasing emphasis on personalized medicine will lead to sizable demand in the market.

The report on the radioimmunoassay market covers the following areas:

• Radioimmunoassay market sizing
• Radioimmunoassay market forecast
• Radioimmunoassay market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radioimmunoassay market vendors that include ALPCO, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Danaher Corp., Enzo Biochem Inc., Merck KGaA, MP BIOMEDICALS, OriGene Technologies Inc., PerkinElmer Inc, Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the radioimmunoassay market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global radioimmunoassay market 2018 - 2022
• 4.2 Application Segment Analysis 2018 - 2022
• 4.3 Product Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Application

• 6.1 Market segments
• 6.2 Comparison by Application
• 6.3 Clinical diagnostics - Market size and forecast 2023-2028
• 6.4 Research - Market size and forecast 2023-2028
• 6.5 Market opportunity by Application

7 Market Segmentation by Product

• 7.1 Market segments
• 7.2 Comparison by Product
• 7.3 Reagents and kits - Market size and forecast 2023-2028
• 7.4 Analyzers - Market size and forecast 2023-2028
• 7.5 Market opportunity by Product

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 ALPCO
• 12.4 Beckman Coulter Inc.
• 12.5 Bio Rad Laboratories Inc.
• 12.6 BioVendor Laboratorni medicina AS
• 12.7 Danaher Corp.
• 12.8 Enzo Biochem Inc.
• 12.9 Merck KGaA
• 12.10 MP BIOMEDICALS
• 12.11 OriGene Technologies Inc.
• 12.12 PerkinElmer Inc
• 12.13 Siemens Healthineers AG
• 12.14 Tecan Trading AG
• 12.15 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations